Effect of Orally Administered Probenecid on the Pharmacokinetics of Cefoxitin

Overview

Journal Antimicrob Agents Chemother

Publisher American Society for Microbiology

Specialty Pharmacology

Date 1980 May 1

PMID 7396472

Citations 9

Authors

P H Vlasses

A M Holbrook

J J Schrogie

J D Rogers

R K Ferguson

W B ABRAMS

Affiliations

Soon will be listed here.

Abstract

To characterize the effect of orally administered probenecid on the pharmacokinetics of cefoxitin in healthy male volunteers, we administered to one group of six subjects 2 g of cefoxitin by intravenous (i.v.) bolus either alone, with 1 g of probenecid concomitantly, or when 1 g of probenecid was administered 1 h previously by using a crossover design. Likewise, we administered to a second group of six subjects 2 g of cefoxitin intramuscularly (i.m.) together with 1 and 2 g of probenecid. Probenecid increased the mean terminal half-life and the area under the serum cefoxitin concentration-time curve (AUC0-24) and decreased renal clearance, but did not alter the volume of the central compartment or the total urinary recovery of i.v.-administered cefoxitin; pretreatment with probenecid produced a greater increase in cefoxitin AUC0-24 and a constant decrease in renal clearance compared to concomitant probenecid. The AUC0-24 after i.m.-administered cefoxitin was greater after 2 g than 1 g of probenecid; the AUC0-24 after i.v.-and i.m.-administered cefoxitin was similar after 1 g of probenecid was given concomitantly. Cefoxitin AUC0-24 was increased further when 1 g of probenecid was given before i.v.-administered cefoxitin or when 2 g of probenecid was given with i.m.-administered cefoxitin. The effect of probenecid was related to both timing and dose.

Citing Articles

Evaluation of Renal Anionic Secretion Following Living-donor and Deceased-donor Renal Transplantation: A Clinical Pharmacokinetic Study of Cefoxitin Microdosing.

Kalluri H, Sood P, Zhao W, Randhawa P, Tevar A, Hariharan S Transplant Direct. 2020; 6(6):e561.

PMID: 33062845 PMC: 7531749. DOI: 10.1097/TXD.0000000000001001.

Inhibitory Effects of Probenecid on Pharmacokinetics of Tenofovir Disoproxil Fumarate and Emtricitabine for On-Demand HIV Preexposure Prophylaxis.

Liu S, Gufford B, Lu J, Bushman L, Anderson P, Bergstrom R Clin Pharmacol Ther. 2019; 107(5):1200-1208.

PMID: 31675437 PMC: 7703849. DOI: 10.1002/cpt.1714.

Renal Drug Transporters and Drug Interactions.

Ivanyuk A, Livio F, Biollaz J, Buclin T Clin Pharmacokinet. 2017; 56(8):825-892.

PMID: 28210973 DOI: 10.1007/s40262-017-0506-8.

Population pharmacokinetics of prophylactic cefoxitin in patients undergoing colorectal surgery.

Isla A, Troconiz I, de Tejada I, Vazquez S, Canut A, Muriel Lopez J Eur J Clin Pharmacol. 2012; 68(5):735-45.

PMID: 22246211 DOI: 10.1007/s00228-011-1206-1.

Competitive inhibition of renal tubular secretion of ciprofloxacin and metabolite by probenecid.

Landersdorfer C, Kirkpatrick C, Kinzig M, Bulitta J, Holzgrabe U, Jaehde U Br J Clin Pharmacol. 2010; 69(2):167-78.

PMID: 20233180 PMC: 2824478. DOI: 10.1111/j.1365-2125.2009.03564.x.

References

Gibaldi M, Schwartz M . Apparent effect of probenecid on the distribution of penicillins in man. Clin Pharmacol Ther. 1968; 9(3):345-9. DOI: 10.1002/cpt196893345. View

Jusko W, Gibaldi M . Effects of change in elimination on varous parameters of the two-compartment open model. J Pharm Sci. 1972; 61(8):1270-3. DOI: 10.1002/jps.2600610820. View

Foord R . Cefuroxime: human pharmacokinetics. Antimicrob Agents Chemother. 1976; 9(5):741-7. PMC: 429614. DOI: 10.1128/AAC.9.5.741. View

Yeh K . Kinetic parameter estimation by numerical algorithms and multiple linear regression: theoretical. J Pharm Sci. 1977; 66(12):1688-91. DOI: 10.1002/jps.2600661208. View

Yeh K, Kwan K . A comparison of numerical integrating algorithms by trapezoidal, Lagrange, and spline approximation. J Pharmacokinet Biopharm. 1978; 6(1):79-98. DOI: 10.1007/BF01066064. View

Reeves D, Bint A, HOLT H, Stocks P . Cefoxitin sodium: a clinical and pharmacological study. J Antimicrob Chemother. 1978; 4(B):155-60. DOI: 10.1093/jac/4.suppl_b.155. View

Schrogie J, Davies R, Yeh K, Rogers D, Holmes G, Skeggs H . Bioavailability and pharmacokinetics of cefoxitin sodium. J Antimicrob Chemother. 1978; 4(B):69-78. DOI: 10.1093/jac/4.suppl_b.69. View

Brogden R, Heel R, Speight T, Avery G . Cefoxitin: a review of its antibacterial activity, pharmacological properties and therapeutic use. Drugs. 1979; 17(1):1-37. DOI: 10.2165/00003495-197917010-00001. View

Berg S, Kilpatrick M, HARRISON W, McCutchan J . Cefoxitin as a single-dose treatment for urethritis caused by penicillinase-producing Neisseria gonorrhoeae. N Engl J Med. 1979; 301(10):509-11. DOI: 10.1056/NEJM197909063011001. View

10.

Rodriguez N, Madsen P, Welling P . Influence of probenecid on serum levels and urinary excretion of cinoxacin. Antimicrob Agents Chemother. 1979; 15(3):465-9. PMC: 352685. DOI: 10.1128/AAC.15.3.465. View

11.

Ungethum W, Pabst J, Dingeldein E, Leopold G . Clinical pharmacology phase I of cefazedone, a new cephalosporin, in healthy volunteers. III. Investigations of the mechanism of renal elimination. Arzneimittelforschung. 1979; 29(2a):443-8. View

12.

Welling P, Dean S, Selen A, Kendall M, Wise R . Probenecid: an unexplained effect on cephalosporin pharmacology. Br J Clin Pharmacol. 1979; 8(5):491-5. PMC: 1429805. DOI: 10.1111/j.1365-2125.1979.tb01032.x. View

13.

Liu C, Hinthorn D, Hodges G, Harms J, Couchonnal G, Dworzack D . Penetration of cefoxitin into human cerebrospinal fluid: comparison with cefamandole, ampicillin, and penicillin. Rev Infect Dis. 1979; 1(1):127-31. DOI: 10.1093/clinids/1.1.127. View

14.

Webb D, Thadepalli H, Bach V . Cefoxitin therapy for bacterial endocarditis. Rev Infect Dis. 1979; 1(1):170-4. DOI: 10.1093/clinids/1.1.170. View

15.

Schrogie J, Rogers J, Yeh K, Davies R, Holmes G, Skeggs H . Pharmacokinetics and comparative pharmacology of cefoxitin and cephalosporins. Rev Infect Dis. 1979; 1(1):90-8. DOI: 10.1093/clinids/1.1.90. View

16.

BURNELL J, KIRBY W . Effectiveness of a new compound, benemid, in elevating serum penicillin concentrations. J Clin Invest. 1951; 30(7):697-700. PMC: 436299. DOI: 10.1172/JCI102482. View

17.

WEINER I, Washington 2nd J, MUDGE G . On the mechanism of action of probenecid on renal tubular secretion. Bull Johns Hopkins Hosp. 1960; 106:333-46. View

18.

Nauta E, Mattie H, Goslings W . Effect of probenecid on the apparent volume of distribution and elimination of cloxacillin. Antimicrob Agents Chemother. 1974; 6(3):300-3. PMC: 444640. DOI: 10.1128/AAC.6.3.300. View

19.

Goodwin C, Raftery E, Goldberg A, Skeggs H, Till A, Martin C . Effects of rate of infusion and probenecid on serum levels, renal excretion, and tolerance of intravenous doses of cefoxitin in humans: comparison with cephalothin. Antimicrob Agents Chemother. 1974; 6(3):338-46. PMC: 444649. DOI: 10.1128/AAC.6.3.338. View